Skip to main content
Clinical Trials/NCT04223726
NCT04223726
Active, not recruiting
Not Applicable

Chronic Arterial Disease, Quality of Life and Mortality in Chronic Kidney Injury

Turku University Hospital1 site in 1 country210 target enrollmentAugust 22, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Kidney Diseases
Sponsor
Turku University Hospital
Enrollment
210
Locations
1
Primary Endpoint
Mortality
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

CADKID-study is a prospective follow-up study assessing arterial disease, quality of life, mortality and their predictors in patients with severe chronic kidney disease.

Detailed Description

Chronic kidney disease (CKD) is associated with increased risk of cardiovascular disease and mortality as well as impaired quality of life. Participants of this study all have severe CKD, defined as estimated glomerular filtration rate \< 30 ml/min per 1.73 m\^2. Stress ergometry, echocardiography, ultrasound assessment of arterial intima-media thickness, lateral lumbar radiograph, ECG, laboratory tests and quality of life assessment were performed at the baseline of the study and will be repeated during follow-up. Atrial fibrillation and other cardiac arrhythmias as well as pulse wave velocity measurements will be explored. Diet diaries are gathered and analysed. The aim of the study is to identify factors associated with cardiovascular disease, quality of life and mortality in this cohort.

Registry
clinicaltrials.gov
Start Date
August 22, 2013
End Date
December 31, 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • estimated glomerular filtration rate \< 30 ml/min per 1.73 m\^2

Exclusion Criteria

  • age under 18 years
  • inability to give informed consent

Outcomes

Primary Outcomes

Mortality

Time Frame: 5 years

Cardiovascular morbidity

Time Frame: 5 years

Secondary Outcomes

  • Changes in quality of life(2 years, 5 years)
  • Rate of hospitalizations(2 years, 5 years)
  • Carotid intima-media thickness(2 years, 5 years)
  • Maximal bicycle stress ergometry performance(2 years, 5 years)
  • Femoral intima-media thickness(2 years, 5 years)
  • Flow-mediated dilatation of brachial artery(2 years, 5 years)
  • Cardiac diastolic function(2 years, 5 years)
  • Number of participants with cardiac arrhythmias(2 years, 5 years)
  • Abdominal aortic calcification (AAC) score(2 years, 5 years)
  • Left ventricular hypertrophy(2 years, 5 years)
  • Cardiac systolic function(2 years, 5 years)

Study Sites (1)

Loading locations...

Similar Trials